SMMTSummit Therapeutics Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 21778
Ticker: SMMT
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2015-03-05
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: SMMT

Detail

Enriched 2026-08-14 20:47

Market cap: $12,046,018,990.2
Shares outstanding (class): 797,749,602
Shares outstanding (weighted): 797,749,602
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 265
Location: MIAMI, FL
Homepage: https://www.smmttx.com
Description: Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.

Market cap and share counts drift.

Funds holding this security

96 funds · 101 positions · $470.70M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$112.78M	1.04%	5,948,323 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$92.27M	1.24%	4,866,448 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$71.20M	0.00%	3,755,154 NS	FIGI
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$50.81M	0.03%	2,680,105 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$32.58M	0.04%	1,718,526 NS	FIGI
VANGUARD SMALL-CAP VALUE INDEX FUND VANGUARD INDEX FUNDS	VBR	$32.37M	0.05%	1,707,539 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$15.16M	0.19%	799,477 NS	FIGI
iShares Russell Mid-Cap Growth ETF iShares Trust	IWP	$14.84M	0.08%	782,939 NS	FIGI
Fidelity Contrafund Fidelity Contrafund	—	$9.27M	0.01%	489,110 NS	FIGI
iShares Russell 1000 Growth ETF iShares Trust	IWF	$9.12M	0.01%	480,979 NS	FIGI
iShares Russell Mid-Cap ETF iShares Trust	IWR	$8.52M	0.02%	449,261 NS	FIGI
abrdn Healthcare Investors —	—	$8.10M	0.71%	427,133 NS	FIGI
T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC.	—	$6.88M	1.04%	362,900 NS	FIGI
abrdn Life Sciences Investors —	—	$4.52M	0.81%	238,231 NS	FIGI
iShares Core S&P Total U.S. Stock Market ETF iShares Trust	ITOT	$4.00M	0.01%	210,850 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERSMMT
FIGI_COMPOSITEBBG00X3GQL76
FIGI_SHARE_CLASSBBG00X3GQL94
CIK0001599298
ISINUS86627T1088
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.9
Model: deepseek
Rationale: SIC 2834 indicates pharmaceutical preparations, so the security is classified as equity in the healthcare sector, pharmaceuticals industry.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.